dr. karen reckamp evaluates the predictive efficacy of the veristrat in nsclc
Published 11 years ago • 284 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
2:24
dr. reckamp on met-targeting strategies in nsclc
-
1:02
dr. reckamp on mk-2206 for the treatment of egfr wild-type nsclc
-
0:49
dr. reckamp on molecular testing in lung cancer
-
1:10
dr. reckamp discusses heat shock proteins in lung cancer
-
1:11
dr. reckamp on targeted therapy options for rare mutations in nsclc
-
32:46
lenvatinib pembrolizumab in rcc, the clear trial with karine tawagi
-
0:41
dr. reckamp describes the use of heat shock proteins
-
5:51
karen reckamp, md, ms: results in phase ii advanced lung cancer trial
-
1:15:52
the curious road from poxvirus tropism to oncolytic virotherapy - grant mcfadden
-
19:08
what dying children and their parents taught justin baker, m.d., about leaning into suffering
-
1:04:50
a new kind of heroism: extreme measures at the end of life
-
1:52
dr. powles on monitoring immunotherapy effects in patients with rcc
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
2:33
doctor explains kidney cancer focal therapy
-
1:14
dr. david spigel discusses the evolving non-small cell lung cancer treatment landscape
-
5:42
what is the integrative oncology?
-
5:14
doctor explains cornell fort prostate cancer clinical trial
-
34:23
lung cancer survivorship
-
8:55
sparcl1 and the colorectal carcinoma microenvironment
-
4:25
analytical research on cell response mechanisms related to diseases